The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> Analyst Interviews >> February 23, 2026

Life Science Tools Leaders Agilent, Danaher Trade Below Fair Value

Utterback, Julie
Julie Utterback, CFA, is a Senior Equity Analyst, Healthcare, for Morningstar. She focuses on medical technology and service companies. She covers managed care organizations including UnitedHealth, service providers like HCA, medical suppliers such as Baxter, and life sciences companies like Danaher. She is also the chairperson of the equity research team’s capital allocation methodology. Before joining Morningstar in 2005, Ms. Utterback was an equity analyst at State Farm Insurance for several years. Ms. Utterback started at Morningstar as an equity analyst in the health care industry and primarily covered medical technology companies, including orthopedic devices, medical equipment, and cardiac device firms. In 2010, she joined Morningstar’s credit research team, initiating coverage of the entire health care industry and generally helping the organization expand and maintain its credit coverage across many industries. She held that senior credit analyst role until April 2019, when she returned to the equity team to cover medical technology and service companies. Ms. Utterback holds a bachelor’s degree in finance from the University of Illinois Urbana-Champaign’s Gies College of Business. She also holds the Chartered Financial Analyst designation. Profile
Word count: 2,974

TWST: In the context of an introduction to your coverage, could you define the life sciences space, and discuss how it differs from the biotech or medtech

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
$TDW, Tidewater’s Supply Moat Widens as High Construction Costs Make New Vessels Financially Unviable for Competitors
Booking Holdings $BKNG: Scale Moat and Strategic OpenAI Pivot Neutralize AI Disruption Fears
Supply Constraints Translate Into Pricing Power for Eagle Materials
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy